Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001653477-25-000101
Filing Date
2025-07-09
Accepted
2025-07-09 09:23:04
Documents
6
Period of Report
2025-07-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1752067377.html 4  
1 FORM 4 wk-form4_1752067377.xml 4 3341
2 EX-24 ngvt_poax-xedgarxnextfis.htm EX-24 9413
3 ngvt_poax-xedgarxnextfis001.jpg GRAPHIC 249083
4 ngvt_poax-xedgarxnextfis002.jpg GRAPHIC 227003
5 ngvt_poax-xedgarxnextfis003.jpg GRAPHIC 44566
6 ngvt_poax-xedgarxnextfis004.jpg GRAPHIC 59564
  Complete submission text file 0001653477-25-000101.txt   813745
Mailing Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405
Business Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405 8437402300
Ingevity Corp (Issuer) CIK: 0001653477 (see all company filings)

EIN.: 474027764 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2800 Chemicals & Allied Products
(CF Office: 08 Industrial Applications and Services)

Mailing Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405
Business Address
Fisher Ryan C. (Reporting) CIK: 0002017486 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37586 | Film No.: 251112429